1) release in vitro
体外释放度
1.
Study of Pseudoephedrine Hydrochloride Sustained-release Preparations and Its Release in vitro;
盐酸伪麻黄碱缓释制剂的研制及其体外释放度测定
2.
Studies on the Preparation and release in vitro of budesonide pulsatile controlled-release tablet for colon-specific delivery;
布地奈德结肠靶向脉冲片的制备及体外释放度研究
3.
Preparation of Gensenosides Microbore Osmotic Pump Tablet and Investigation of Release in vitro
人参总皂苷渗透泵片制备及体外释放度考察
2) in vitro release
体外释放度
1.
Preparation and the in vitro release of stavudine extended-release pellets capsules;
司他夫定缓释微丸胶囊的制备与体外释放度考察
2.
Evaluation of the in vitro release rate of doxycycline hyclate in the injectable gel delivery system;
盐酸多西环素注入用缓释凝胶的体外释放度研究
3.
The relationship of water content, viscosity and in vitro release of the product prepared by optimized formulation was examined.
考察了对盐酸西替利嗪巴布剂黏性影响较重要的3个辅料的用量,并研究了优化处方的含水量、黏性及体外释放度的关系。
3) Release rate in vitro
体外释放度
1.
Preparation of Naoluokang Sustained Release Capsules and Their Release Rate in Vitro;
脑络康缓释胶囊的制备工艺和体外释放度的研究
2.
Preparation of vaginal tinidazole microcapsules and observation of its release rate in vitro;
阴道用替硝唑缓释微囊的制备及其体外释放度考察
3.
Aim To prepare puerarin enteric nanoparticles and investigate their release rate in vitro.
目的制备葛根素肠溶纳米粒,并对其体外释放度进行考察。
4) in vitro release rate
体外释放度
1.
Study on preparation of vitamin C sustained-release tablets and determination of in vitro release rate;
维生素C微囊缓释片的制备及体外释放度实验
2.
Objective:To establish the method and the in vitro release rate of gexintong sustained tablets.
目的:确定葛心通缓释片的体外释放度的测定方法及其体外释放度。
3.
Objective:To study the effects of formulation factors on in vitro release rate of ondan- setron hydrochloride (OND)-loaded microspheres.
目的:考察处方工艺参数对微球体外释放度的影响。
5) dissolution in vitro
体外释放度
1.
Method:The dissolution in vitro of VIN-SEDDS were determined.
方法:进行了体外释放度实验,考察释放度实验方法学、释放介质、转速和制剂因素对药物释放特性的影响。
补充资料：体外释放
分子式：
CAS号：
性质：即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂，通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃，释放介质为人工胃液和人工肠液，有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样，并及时补充所消耗的溶媒。
CAS号：
性质：即将固体药物制剂模拟体内情况在体外所进行的释放试验。体内情况极为复杂，通常只能在温度、搅拌、介质pH值等方面加以模拟。具体实验方法因制剂类型、用途和理化性质等而异。口服缓释或控释制剂一般试验条件为温度37℃，释放介质为人工胃液和人工肠液，有时也可用水。常用的容器有转篮式、桨式、循环式及崩解仪式等数种。在规定时间取样，并及时补充所消耗的溶媒。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条